Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
D000682:Amyloid / Q000276:immunology*; D000686:Amyloidosis / Q000628:therapy*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008954:Models, Biological
D000682:Amyloid; D000911:Antibodies, Monoclonal